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Bone apatite consists in carbonated calcium deficient hydroxyapatite nanocrystals (CDHA). 
Biomimetic routes allow fabricating synthetic bone grafts that mimic biological apatite. In this 
work, we explored the role of two distinctive features of biomimetic apatites, namely nanocrystal 
morphology (plate vs. needle-like crystals) and carbonate content on the bone regeneration 
potential of CDHA scaffolds in an in vivo canine model. Both ectopic bone formation and 
scaffold degradation were drastically affected by the nanocrystal morphology after intramuscular 
implantation. Fine-CDHA foams with needle-like nanocrystals, comparable in size to bone 
mineral, showed a markedly higher osteoinductive potential and a superior degradation than 
chemically identical Coarse-CDHA foams with larger plate-shaped crystals. These findings 
correlated well with the superior bone healing capacity showed by the Fine-CDHA scaffolds 
when implanted intraosseously. Moreover, carbonate doping of CDHA, which resulted in small 
plate-shaped nanocrystals, accelerated both the intrinsic osteoinduction and the bone healing 
capacity, and significantly increased the cell-mediated resorption. These results suggest that 
tuning the chemical composition and the nanostructural features may allow the material to enter 
the physiological bone remodelling cycle, promoting a tight synchronization between scaffold 
degradation and bone formation. 
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Bone is a nanocomposite material whose major constituents are collagen microfibrils and 
nanocrystallites of a calcium phosphate (CaP) with apatite structure. The mineral phase 
represents, in fact, around 65 wt% of the bone extracellular matrix.1 This is the reason why 
CaPs have been the preferred option when designing synthetic bone grafts, most bone 
substitutes currently in the market being either hydroxyapatite (HA), beta-tricalcium phosphate 
(β-TCP) or a combination of both.2 
However, although in a broad sense these materials bear some resemblance with the bone 
mineral, a closer look reveals major differences. Bone apatite is a highly carbonate-substituted, 
calcium deficient form of hydroxyapatite (Ca10(PO4)6(OH)2), with a high vacancy content,3 and 
containing, in addition to carbonate, other trace elements such as Mg2+, Fe2+, Zn2+,K+, Na+, 
(HPO4)2-, F- and Cl-.4 This results in a distorted network with poor crystallinity. The carbonate 
ions can substitute both hydroxyl or phosphate groups in the apatite crystal structure, originating 
the A-type and B-type carbonation, respectively, B-type being the preferred form in biological 
apatite.3 Bone mineral is produced by precipitation from the supersaturated extracellular fluids, 
resulting in plate-shaped nanocrystals of variable lengths (30-50 nm) and thickness (average 
about 5 nm), located both within the collagen fibres, and also in the extrafibrillar space.5 Recent 
studies, moreover, have shown evidence that the extrafibrillar mineral has the form of elongated 
plates about 5 nm thick, 60 nm wide and several hundreds of nm long.6,7
This is in contrast to conventional CaP bone substitutes, which are commonly obtained by high 
temperature sintering processes, resulting in a lack of nanostructure, and of a chemical 
composition far from biological apatites.1 Although they are biocompatible and osteoconductive, 
their bone healing capacity is still inferior to that of autologous bone grafts, specifically in terms 
of the initial osteoinduction, as well as the progressive graft resorption.8,9 In consequence, 
autografts are still considered the gold standard treatment, despite the major disadvantages 
related to the secondary harvesting surgical procedure.10 In this work, we propose mimicking 
much more closely the chemical and nanostructural properties of biological apatite as a strategy 
to enhance the biological performance of synthetic bone grafts.
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In previous studies we have shown that calcium deficient hydroxyapatite (CDHA) scaffolds can 
be obtained by biomimetic routes, which allow tuning not only the size but also the shape of the 
precipitated apatite nanocrystals.11,12 Moreover, in order to increase the chemical similarity to 
natural bone, carbonate can be introduced in the apatite by a novel biomimetic process to 
obtain carbonated nanostructured CDHA foams.13 This provides a very powerful platform to 
tailor the nanostructure and composition of biomimetic bone substitutes. 
Although it was shown previously that biomimetic CDHA foams possess superior osteoinductive 
properties than conventional sintered ceramic foams,14 the relevance of the nanostructure, and 
more specifically, the effect of nanocrystal size and morphology on the in vivo performance of 
these materials is unknown. 
We recently showed through an in vitro study that tuning the nanostructural features of CDHA is 
an effective method to control the response of immune cells.15 This is in line with other in vitro 
studies that have demonstrated that the size and shape of nanocrystals in nanostructured 
biomaterials exert a direct effect on cells involved in osteoinduction.16-19 However, these results 
cannot be extrapolated to the very different in vivo scenario.
Similarly, the presence of carbonate in the apatite structure is known to increase the chemical 
reactivity of HA by disturbing its crystal lattice,20-21 and it has been shown to foster 
osteoclastogenesis,22-25 a critical event in the intrinsic osteoinduction cascade of 
biomaterials.26,27 However, most in vivo studies investigating the behavior of carbonated 
apatites have focused on high temperature ceramics, with absence of nanostructure and limited 
carbonate content,28-37 as the sintering process, in addition to fusing the nanometric crystals, 
causes a severe thermal decomposition of carbonate into CO2 resulting in high carbonate 
losses.38-40
The aim of the present work was to investigate the role of nanocrystal morphology (plate vs. 
needle) and the effect of carbonate doping of nanostructured CDHA foamed scaffolds on their 
intrinsic osteoinduction and degradation behaviour in vivo, and to assess if there is a direct 
correlation with their bone healing capacity. To this end, the performance of nanostructured 
CDHA foams with two different crystal sizes and morphologies were compared using canine 
ectopic and orthotopic implantation models. Plate-shaped nanocrystals were compared with 
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needle-shaped CDHA foams evaluated in our previous studies.14,41 To further mimic bone 
mineral, carbonated CDHA nanostructured foams obtained under biomimetic conditions were 
included as a third group. 
2. Materials and Methods
2.1. Calcium phosphate materials
2.1.1. Synthesis of alpha-tricalcium phosphate powder 
Alpha-tricalcium phosphate (α-TCP) powder was used as precursor of the CDHA foams, and it 
was synthesized as described elsewhere.14 Then, the α-TCP particles were milled using two 
different milling protocols42 in order to obtain two different sizes of α -TCP powder, a coarse 
powder (5.2 μm median size) and a fine powder (2.8 μm median size).
2.1.2. Preparation of foams and discs
CDHA foams were obtained by hydrolysis of α-TCP foams, as previously reported.14,43 Fine or 
coarse α-TCP powders were used to obtain Fine-CDHA or Coarse-CDHA foams, respectively. 
The liquid to powder ratio was adjusted to obtain similar macroporosities for both type of foams, 
being ratios of 0.65 and 0.55 mL/g for fine and coarse α-TCP powders, respectively. Foaming 
was performed with a customized domestic food mixer for 30 s at 7000 rpm and the resulting 
foams were transferred to Teflon cylindrical moulds (5 mm diameter and 10 mm height), which 
were left in humid atmosphere at 37 ºC for 8 h to ensure cohesion of the foamed structures. 
Afterwards, the scaffolds were immersed in water for 10 days at 37 ºC to allow for the hydrolysis 
of α-TCP to CDHA. The carbonated CDHA foams (CO3-CDHA) were obtained by immersing the 
coarse α-TCP foams in a saturated sodium bicarbonate (NaHCO3, Sigma-Aldrich, St. Louis, 
MO) solution instead of water, in this case for 17 days to complete the hydrolysis reaction.13
For the in vitro assays, 5 mm diameter x 0.3 mm height discs were prepared of all three groups, 
applying the same protocol used to fabricate the foamed scaffolds, but mixing the solution in a 
mortar for 1 min instead of the foaming step.
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Phase characterization of the different samples was performed by X-ray diffraction, as 
previously described.14 Samples were analyzed also by Attenuated Total Reflectance Fourier-
transform infrared spectroscopy analysis (ATR-FTIR) and carbonate quantification was 
performed by bulk combustion element analyzer using the conditions reported in a previous 
study.13 The specific surface area (SSA) was measured by nitrogen adsorption, porosity and 
pore entrance size distribution were quantified by mercury intrusion porosimetry (MIP), and the 
microstructure was determined by scanning electron microscopy (SEM) after coating the 
samples with carbon.14 Finally, the macroporosity of the foamed scaffolds was characterized by 
micro-computed tomography (micro-CT), as described elsewhere.14
2.2. In vitro study
2.2.1. Cell culture
To better understand the effect of nanocrystal morphology and carbonate doping, rat 
mesenchymal stem cells (rMSCs) were seeded on the surface of discs of all three materials 
(Fine-CDHA, Coarse-CDHA and CO3-CDHA), as previously reported.14 Briefly, cells were 
expanded in AdvDMEM supplemented with 10% FBS, 20 mM HEPES buffer, 2 mM L-glutamine 
and penicillin/streptomycin (50 U/mL and 50µg/mL, respectively). In all experiments, cells at 
passages 3-4 were used.
2.2.2. Cell proliferation
For the proliferation assay, all samples were tested at 6 h, 3, 7 and 14 days. The experiments 
were performed with three replicates of each sample and tissue culture polystyrene (TCPS) was 
used as control. Cells were seeded at a density of 300 cells/mm2. Samples were changed into 
another plate at each specified time and cell lysis was performed using 300 µl of M-PER® 
(Mammalian Protein Extraction Reagent, Thermo Scientific Inc., Waltham, MA). Subsequently, 
cell number was measured using the Cytotoxicity Detection KitPLUS (Hoffmann-La Roche, 
Basel, Switzerland) and lactate dehydrogenase (LDH) activity was determined 
spectrophotometrically at 492 nm (Synergy HTX, BioTek Instruments Inc., Winooski, VT). To 
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present the results, a calibration curve with decreasing number of cells was prepared and all 
values were normalized by total seeded area.
2.2.3. Cell morphology
Cell seeded discs were observed by SEM (Zeiss Neon40 EsBCrossBeam, Zeiss, Oberkochen, 
Germany) after 14 days. Samples were washed with PBS three times and fixed for 1 h at 4ºC in 
a 2.5 % glutaraldehyde (Sigma-Aldrich, St. Louis, MO) solution in PBS. Subsequently, fixed 
samples were washed three times with PBS and dehydrated in increasing series of ethanol 
solutions. Complete dehydration was performed in hexamethyldisilazane (HMDS,Thermo 
Scientific Inc., Waltham, MA) and discs were stored in desiccator. Dried disks were covered with 
a thin gold-palladium layer using vapor deposition.
Cell morphology was further analyzed by confocal microscopy using immunofluorescent staining 
to visualize nuclei, actin stress fibres and osteocalcin after 14 days of culture. The attached cells 
were rinsed with PBS (x3) and fixed in 4% paraformaldehyde (PFA, Sigma-Aldrich, St. Louis, 
MO) solution in PBS. Afterwards, cells were permeabilized with 0.1% Triton X-100 (Sigma-
Aldrich, St. Louis, MO) in PBS for 15 min and blocked with 1% bovine serum albumin (BSA, 
Sigma-Aldrich, St. Louis, MO) in PBS for 1 h. Then, discs were incubated for 1 h with rabbit anti-
osteocalcin (G-5, Santa Cruz Biotechnology Inc., Dallas, TX) (1:100 in 1% BSA in PBS). 
Subsequently, Alexa Fluor 488 chicken anti-rabbit and Alexa Fluor 546 phalloidin (Thermo 
Scientific Inc., Waltham, MA) were added and incubated for 1 h (1:1000 and 1:300 in 0.1% 
Triton X-100 in PBS, respectively). For nuclei staining, discs were incubated with 4’,6-diamidino-
2-phenylindole (DAPI) for 2 min. Three rinses of 5 min each in 0.15 % glycine (Sigma-Aldrich, 
St. Louis, MO) in PBS were done between all steps. Sample discs were mounted in Mowiol 4-88 
(Sigma-Aldrich, St. Louis, MO) and visualized in a confocal microscope (Leica TCS SPE, Leica 
Microsystems, Wetzlar, Germany). Digital images were processed using an image analysis 
software (Fiji/Image-J package, open source software).
2.2.4. Cell differentiation
The osteoblastic differentiation was determined by quantifying the expression of osteogenic 
genes by Real-Time quantitative Polymerase Chain Reaction (RT-qPCR), as previously 
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reported.14 Briefly, cells were seeded on the discs (300 cells/mm2) and incubated for 6 h and 1 
and 3 days. Additionally, for osteocalcin (OCN) late marker, 7 and 14 days were also monitored. 
Total RNA was extracted using RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany) and 
quantified by NanoDrop ND-1000 spectrophotometer (NanoDrop Products, Thermo Fisher 
Scientific Inc., Waltham, MA). In order to ensure that cell number is not influencing the results, 
equal amounts of RNA (120 ng) were retrotranscribed to cDNA using the QuantiTect Reverse 
Transcription Kit (Qiagen GmbH, Hilden, Germany) and then specifically amplified using 
selective primers.14 The expression values of studied genes were normalized by expression of 
β-actin, a housekeeping gene that acts as an internal control of cell number, and relative fold 
changes (FC) were related to tissue culture polystyrene (TCPS) at 6 h of culture, following a 
previously established formula.14 The experiment was performed in two independent runs.”
2.3. In vivo study
Ethical approval for the in vivo assays was obtained from the local ethics committee (CEAAH 
2338) and all procedures were performed in compliance with the Guide for Care and Use of 
Laboratory Animals44 as well as the European Community Guidelines (Directive 2010/63/EU) for 
the protection of animals used for scientific purposes.45 Surgeries were performed in twelve 
adult beagle dogs (14-17 kg) following standard anesthetic and analgesic protocols.14
2.3.1. Intramuscular implantation
The intrinsic osteoinductive potential of the materials was evaluated in a standardized 
intramuscular canine model.14 Briefly, once the animals were anesthetized, the lumbar skin and 
fascia were incised and three intramuscular pockets were created in the epaxial muscles of 
each dog. Subsequently, each intramuscular pocket was filled with one of the three foamed 
scaffolds (5 mm of diameter x 10 mm of length). 
2.3.2. Intraosseous implantation
To study the bone healing capacity of the same scaffolds, their potential to repair a femoral 
monocortical bone defect was evaluated in a standardized intraosseous canine model,41 in the 
same group of animals. Briefly, three monocortical bone defects (5 mm of diameter) were drilled 
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on the mid-shaft femoral diaphysis, and one scaffold (5 mm of diameter x 10 mm of length) of 
each group was placed in each defect by press-fit.
During the postoperative period, dogs were medicated with a long-acting antibiotic and a non 
steroidal anti-inflammatory drug for 7 days, which is routinely prescribed after orthopedic 
surgeries. Finally, six animals were euthanized at each experimental time (6 and 12 weeks post-
implantation) by an overdose of pentobarbital sodium.
To sum up, one scaffold of each group (Fine-CDHA, Coarse-CDHA and CO3-CDHA) was 
implanted intramuscularly and intraosseously in each dog, resulting in six intramuscular and six 
intraosseous scaffolds per group and evaluation time, as summarized in the Supporting 
Information (Figure S1).
2.3.3. Sample harvest and histological processing
After euthanasia, samples were immediately harvested and fixed in a buffered formalin solution 
for 72 h.  The specimens were then dehydrated in a graded ethanol series, and embedded in 
ascending graded mixtures of ethanol and methylmethacrylate resin (Technovit 7200, Heraeus 
Kulzer GmbH, Hanau, Germany) that photopolymerized under white and ultraviolet light for 2 
and 4 h, respectively. The resulting blocks were analyzed by micro-CT. After micro-CT 
scanning, each block was divided into two equal pieces. Intramuscular samples were divided 
transversally and intraosseous samples longitudinally to evaluate the full thickness of the 
cortical bone defect. One half of each sample was polished and coated with carbon for 
backscattered scanning electron microscopy analysis (BS-SEM).14 The other half was sliced 
and grinded to obtain histological sections (50 μm). Sections were then stained with Goldner-
Masson trichrome (GMT) and toluidine blue (TB) for histological evaluation.14
2.3.4. Histology and histomorphometry
The 3D evaluation of the samples was performed by micro-CT (SkyScan 1172, Bruker Corp., 
Billerica, MA), as previously established.46 The specimen was rotated through 180º with a 
rotation step of 0.40º, an acquisition time of 2.1 s per scan and anisotropic pixel size of 5 µm for 
the intramuscular samples and 10 µm for the intraosseous samples. The same 
histomorphometric parameters were measured in both groups of samples: 
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a) Percentage of newly formed bone within the initial available macropore space:
% newly formed bone = (bone volume / initial available macropore volume) * 100
b) Percentage of scaffold degradation, calculated by subtracting the remaining scaffold 
volume from the initial scaffold volume prior to implantation:  
% scaffold degradation = [(initial scaffold volume – final scaffold volume) / initial scaffold volume] * 100
For the intramuscular samples, both parameters were quantified in the entire scaffold volume, 
whereas for the intraosseous samples only the monocortical bone defect volume was 
considered.
The localization and maturity of the newly formed bone were determined based on tissue 
morphology and the different grey levels by BS-SEM imaging at a voltage of 20 kV.
The stained histological sections were observed under light microscopy (Nikon Eclipse E800, 
Nikon Corp.,Tokyo, Japan) to evaluate histological qualitative parameters such as the degree of 
peri-implant inflammatory reaction, neovascularization, fibrous-tissue infiltration and osteoclastic 
activity.
2.4. Statistical analysis 
Data were analyzed using the GraphPad Prism Version 6.0 (GraphPad Software Inc., La Jolla, 
CA) and expressed as mean values ± standard error. A one-way repeated measures ANOVA 
followed by Tukey’s post hoc test were used to detect any differences between groups and 
significance was considered at p <0.05.
3. Results 
3.1. Materials characterization
XRD analysis showed that both the foamed cylinders and the discs consisted of low crystallinity 
hydroxyapatite containing in some cases small amounts of unreacted α-TCP (less than 2%) 
(Figure 1A). The shift observed in the (300) peak (2θ shift from 32.8o to 33o) for the CO3-
CDHA samples indicates a contraction in the a-axis compared to CO3-free samples which is 
consistent with a B-type carbonate substitution.47 The ATR-FTIR spectra showed the typical 
phosphate bands at 570, 600, 960 and 1030 cm-1 for all three groups (Figure 1B).48,49 In 
agreement to the XRD results, the detection of bands at 1471 and 1419 cm-1 in the CO3-CDHA 
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samples confirmed the B-type carbonate substitution in the apatite crystal lattice in these 
specimens.3,50
Figure 1.  Physicochemical characterization of Fine-CDHA, Coarse-CDHA and CO3-CDHA foams and discs: (A) XRD 
patterns. (B) ATR-FTIR spectra (C) Pore entrance size distributions determined by MIP. (D) Low magnification SEM 
images of the implanted foams showing the interconnected spherical concave macropores in all groups and high 
magnification images showing the nanostructure consisting of needle-shaped nanocrystals for the Fine-CDHA foams 
and plate-shaped nanocrystals for the Coarse-CDHA and CO3-CDHA foams, smaller in the latter.
The pore entrance size distribution of the different materials, as determined by MIP, is displayed 
in Figure 1C. The presence of open macroporosity centered at 70 µm was confirmed in the 
three foamed scaffolds, together with pores in the micrometric and nanometric range. As 
expected, the discs, which had not been subjected to the foaming step, showed only 
submicrometric and nanometric pores. SEM images in Figure 1D revealed similar pore size and 
spherical geometry of the macropores in the three foamed materials, and marked differences in 
micro- and nanostructure. Whereas Fine-CDHA scaffolds showed the typical network of 
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entangled needle-like nanocrystals, Coarse-CDHA and CO3-CDHA showed entangled plate-like 
crystals, significantly smaller in the latter.
A detailed quantification of the textural properties as well as carbonate incorporation levels is 
given in Table 1. SSA values varied in accordance with the nanocrystal morphology, being the 
highest for Fine-CDHA samples and the lowest for the Coarse-CDHA group due to the larger 
crystal size (Figure 1D). The carbonate content reached 11-12 wt% in the carbonated samples 
regardless of their dense or foamed nature, being almost negligible for the non-carbonated 
counterparts (Fine-CDHA and Coarse-CDHA).

























Disc 57.7 - - - - 40.18 0.05Fine-CDHA
Foam 76.5 49.5 52.3 70 227.0 38.49 0.03
Disc 51.8 - - - - 21.96 0.05
Coarse-CDHA
Foam 71.1 47.6 49.3 70 302.1 19.26 0.02
Disc 48.0 - - - - 29.81 11.33
CO3-CDHA Foam 69.7 46.7 49.1 70 264.0 30.33 12.33
*Whereas MIP determines the mean entrance size of macropores, micro-CT quantifies the mean pore size itself. 
3.2. In vitro study
3.2.1. Cell adhesion and proliferation
rMSC adhesion after 6 h was very similar in all groups (Figure 2A). However, from this time 
point cell number progressively decreased on Fine- and Coarse-CDHA, whereas it significantly 
increased on CO3-CDHA, with statistically significant differences between groups at 3, 7 and 14 
days of culture. 
3.2.2. Cell morphology
Morphological studies performed by SEM after 14 days of culture showed that the cells seeded 
on all three substrates had similar morphologies and were well spread in all cases (Figure 2B). 
The main difference between groups was the density of cells, in accordance with the results 
obtained in the proliferation assay, with lower cell density on the Coarse- and Fine-CDHA 
groups compared with CO3-CDHA samples.
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Immunofluorescence assays performed at 14 days revealed that actin filaments were not well 
developed in the cells seeded on the Coarse- and Fine-CDHA discs (Figure 2B). In contrast, 
cells seeded on the CO3-CDHA discs showed clearly defined actin filaments, as well as a 
superior osteocalcin activity (Figure 2B), suggesting improved cell differentiation compared with 
the Fine- and Coarse-CDHA groups. 
Figure 2. (A) LDH assay: rMSCs proliferation after 6 h, 3, 7 and 14 days. (*) denotes groups with statistically 
significant differences (p < 0.05). (B) Morphology of rMSCs at 14 days observed by SEM (first column) and by 
confocal microscopy (second and third columns). Nuclei in blue, actin fibers in red and osteocalcin in green. For 
osteocalcin visualization, the regions where cell were present were chosen. The confocal images are not 
representative in terms of cellular density for Fine-CDHA and Coarse-CDHA samples.
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The gene expression results determined by RT-qPCR are displayed in the Supporting 
Information (Figure S2). In general terms, cells seeded on all three materials showed a superior 
osteogenic gene expression compared to those cultured on TCPS, showing significant 
differences at 6 h for BMP-2, Col I and OPN, at 1 day for all osteogenic markers except for ALP, 
and at 3 days for OPN and OCN. Moreover, the expression of OCN at 7 and 14 days was 
significantly higher for the cells cultured on the three CDHA discs than for those cultured on 
TCPS. Among the three nanostructured CDHA materials, the non-carbonated CDHA groups 
showed a slightly superior osteogenic gene expression than CO3-CDHA samples, although no 
statistically significant differences were consistently found between groups.
3.3. In vivo study
There were no surgical and postoperative complications. No adverse foreign body reaction was 
observed in any case, confirming the good biocompatibility of all scaffolds in both implantation 
sides. 
3.3.1. Intramuscular implantation
At 6 weeks, loose connective-tissue infiltration and abundant blood vessel ingrowth were 
observed within the interconnected macropores of all three groups (Figure 3). However, 
significant differences were noted regarding new ectopic bone formation. Whereas newly 
formed bone was found in the Fine-CDHA group in four animals out of six and in the CO3-CDHA 
group in five out of six animals, no signs of bone formation were noted in the Coarse-CDHA 
scaffolds (Figures 3 and 4). The bone observed at 6 weeks mainly consisted in woven bone 
firmly attached to the concave surfaces of scaffold macropores, always formed through an 
intramembranous ossification process. Moreover, a few Haversian structures were observed, in 
which the lamellar bone was arranged concentrically around a central canal, mimicking the 
osteonic structure of cortical bone (Figure 3), 
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Figure 3. Undecalcified Goldner-Masson trichrome stained histological slides (A,B,C) and backscattered scanning 
electron micrographs (D,E,F) after 6 weeks of intramuscular implantation. All groups showed loose fibrous-tissue 
(FT) infiltration and abundant blood vessel (arrow heads) ingrowth within the interconnected macropores. Note the 
new osteoid in pink and the well-mineralized bone matrix in dark green in the GMT stained sections. In BS-SEM 
images the calcified bone appears in light grey. Interestingly, only Fine-CDHA and CO3-CDHA groups showed new 
ectopic bone formation (arrows) at this time point, always firmly attached to the material (M) concave surfaces. 
(G,H,I) Backscattered scanning electron micrographs showing some Haversian structures (white arrows), in which 
new bone is arranged concentrically surrounding a central blood vessel replicating the osteonic structure of cortical 
bone. ST=Soft tissue, M=Material. 
Figure 4. (A) Ectopic bone incidence after 6 and 12 weeks of intramuscular implantation. (B) Percentage of newly 
formed bone within the available macropore space after 6 and 12 weeks of intramuscular implantation, as 
determined by micro-CT. (*) Statistically significant differences between groups (p < 0.05). 
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A similar trend was observed after 12 weeks of implantation when a large amount of ectopic 
bone was detected in all animals for Fine-CDHA and CO3-CDHA groups, while in the Coarse-
CDHA group a reduced amount of bone was noted only in two out of six animals (Figure 4). At 
this time point mature lamellar bone was formed on the Fine-CDHA and CO3-CDHA scaffolds 
while mainly woven bone was observed in Coarse-CDHA constructs (Figure 5). 
Figure 5. Histological images of the studied scaffolds after 12 weeks of intramuscular implantation. (A,B,C) 
Backscattered scanning electron images. (D,E,F) Undecalcified Goldner-Masson-trichrome stained histological 
slides. (G,H,I) Undecalcified Toluidine-blue stained histological slides. A significant amount of well-calcified bone 
matrix (grey in the BS-SEM, green in GMT and purple in TB) and some osteon-like structures (arrows) with the 
characteristic Haversian canals (asterisks) in the centre were indentified in the Fine-CDHA and CO3-CDHA foams. In 
contrast, negligible amounts of ectopic bone were observed in the Coarse-CDHA constructs. Note the new osteoid 
(pink in GMT and blue in TB) and osteocytes inside lacunae (light green in GMT and blue in TB). M=Material.  
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Histological evaluation also showed the presence of multinucleated osteoclast-like resorbing 
cells in all samples (Figure 6C). However, a higher amount of osteoclast-like cells were 
observed at both time points in the Fine-CDHA scaffolds, and especially in the CO3-CDHA 
scaffolds, compared with the Coarse-CDHA ones. This was in agreement with the superior 
degradation rate shown by the CO3-CDHA and Fine-CDHA foams compared with the Coarse-
CDHA (Figure 6A), which was more pronounced in the carbonate-containing scaffolds (Figure 
6A/B), although in all cases the differences were statistically significant only after 12 weeks of 
implantation. It is worth noting that, contrary to the other two groups, the degradation of Coarse-
CDHA constructs did not progress overtime (Figure 6A).
Figure 6. (A) Percentage of scaffold degradation 6 and 12 weeks after intramuscular implantation, as determined by 
micro-CT. (*) Statistically significant differences between groups (p <0.05). (B1,B2,B3) Micro-CT 3D reconstructions 
of studied foams 12 weeks after intramuscular implantation. (C1,C2,C3) Undecalcified toluidine-blue stained 
histological slides of scaffolds implanted intramuscularly for 12 weeks showing macrophages and multinucleated 
osteoclast-like cells (arrows) resorbing the materials. Note intracellular material particles visible in some resorbing 
cells (C1,C3). M=Material, Asterisk=Ectopic bone.
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Histological analysis of the scaffolds implanted orthotopically revealed new bone tissue ingrowth 
within open macropores of all three scaffolds, in close contact with the material surfaces and 
without any intervening layer of fibrous tissue at the host cortical bone-material interface 
(Supporting Information, Figure S3A/B/C). Moreover, all groups showed a high degree of 
neovascularization, as observed in the Goldner-Masson-trichrome stained sections (Supporting 
Information, Figure S3D/E/F). 
The main histological finding, however, was that Fine-CDHA and CO3-CDHA scaffolds 
stimulated bone ingrowth further, with the prompt presence of newly formed bone in the centre 
of the scaffolds at the early stage of  6 weeks postimplantation (Figure 7A). Conversely, in the 
Coarse-CDHA scaffolds new bone was formed only in the peripheral areas of the defects at this 
initial evaluation point (Figure 7A). After 12 weeks, complete bridging of bone defects were 
found for the Fine-CDHA and CO3-CDHA scaffolds, whereas bone formation was more limited 
in Coarse-CDHA scaffolds and some empty pores were still noted in the central areas of the 
monocortical bone defects (Figure 7B). 
The micro-CT histomorphometric analysis (Figure 8) confirmed the above-mentioned 
histological observations. Bone formation was significantly higher in the Fine-CDHA and CO3-
CDHA groups than in the Coarse-CDHA group, at both time points, as shown in Figure 8A. 
Moreover, Fine-CDHA and CO3-CDHA groups exhibited also a significantly superior 
degradation than the Coarse-CDHA scaffolds at 12 weeks (Figure 8B). Similarly to what 
happened intramuscularly, the CO3-CDHA scaffolds showed a higher resorption than Fine-
CDHA constructs, especially at 12 weeks, and the resorption of Coarse-CDHA scaffolds did not 
progress significantly overtime (Figure 8B).
The consistent observation of cutting cones and osteoclast-like cells in all groups was a clear 
indication of cell-mediated scaffold resorption and the integration of the material in the bone 
remodelling process (Supporting Information, Figure S3G/H/I). However, similarly to the 
intramuscular study, osteoclast-like cells were more abundant in the Fine-CDHA, and especially 
in the CO3-CDHA scaffolds, than in the Coarse-CDHA foams at both time points.
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Figure 7. Backscattered scanning electron micrographs of a section of the femoral diaphysis, showing the cortical 
bone containing the studied scaffolds, after 6 (A1,A2,A3) and 12 weeks (B1,B2,B3) of implantation.
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Figure 8. Histomorphometrical results obtained by micro-CT after 6 and 12 weeks of intraosseous implantation: (A) 
Percentage of new bone within the monocortical bone defect. (B) Percentage of scaffold degradation. (*) Statistically 
significant differences between groups (p < 0.05). 
4. Discussion
The fabrication of CaP scaffolds using biomimetic routes, based on the hydrolysis of α-TCP to a 
CDHA at body temperature, and avoiding high temperature sintering processes, allowed 
mimicking the properties of bone mineral. As shown in Figure 1, it was possible to tune the 
microstructure and the chemical composition of the biomimetic CDHA, modifying crystal shape 
and size, and consequently the textural properties of the materials. Using α-TCP powders of 
different sizes, either fine or coarse, allowed obtaining CDHA nanocrystals with different 
morphologies, either thin needles about 30-60 nm thick and 300-500 nm long or thin 
submicrometric plates about about 100 nm thick and 700-900 nm wide, respectively, with a 
consequent change in the SSA from 40 m2/g to 20 m2/g (Figure 1D and Table 1). Although the 
crystals obtained were still slightly larger than the ones found in the bone mineral, the 
biomimetic route allowed approaching closely the size and morphology of biological apatite.
Concerning chemical composition, in order to increase the biomimetism of the foams, 
carbonation of the scaffolds was achieved by performing the setting reaction of the coarse α-
TCP foams in a carbonate-containing solution. This resulted in the incorporation of carbonate in 
the CDHA structure as revealed by the displacement of the XRD peaks and the appearance of 
the bands in the ATR-FTIR spectra corresponding to B-type carbonated CDHA, the preferred 
type of carbonate substitution in bone apatite.3,4,36  The amount of carbonate introduced in the 
CDHA was 11-12%, slightly higher than the amount contained in bone apatite, which ranges 
between 4 and 8% depending on the age.51 This was accompanied with a change in 
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microstructure, since small plate-like nanocrystals with intermediate SSA (around 30 m2/g) were 
obtained (Figure 1D and Table 1), in agreement with previous studies.13
The effects of both nanostructure and carbonate substitution in terms of osteoinduction and 
bone healing potential are discussed in the following sections.
4.1 Effect of nanostructure and carbonate doping on osteoinduction
The foams analyzed in the present study presented similar macropore architecture, that is, 
similar percentage of total porosity, macropore volume, macropore geometry, macropore 
entrance size and macropore size values (Figure 1D and Table 1). The good macropore 
interconnectivity fostered a fast neovascularization in all scaffolds (Figure 3). In contrast, very 
different trends were observed in terms of osteoinduction depending on nanostructure and 
chemical composition. After the intramuscular implantation of the scaffolds for 6 weeks, Coarse-
CDHA constructs did not show any sign of ectopic bone formation, while both Fine-CDHA and 
CO3-CDHA exhibited high incidences of ectopic bone formation, being slightly higher for the 
carbonated foams (Figures 3 and 4). Moreover, at 12 weeks postimplantation, these two groups 
showed a considerable amount of newly formed ectopic bone in all dogs, whereas only a small 
amount of ectopic bone was observed in 2 out of 6 animals in the Coarse-CDHA group (Figures 
4 and 5). Considering that the three groups shared the same macropore features, the significant 
differences observed in their osteoinductive potential should be ascribed to the nanostructure 
and composition of the materials. The smaller nanocrystals of the Fine-CDHA and CO3-CDHA 
scaffolds, with the associated larger SSAs compared to the Coarse-CDHA scaffolds, are known 
to enhance surface reactivity increasing the capacity to release calcium and phosphate ions 
upon cell-mediated degradation. Moreover, the reactivity is further promoted by the presence of 
carbonate ions (Figures 6A and 8B). These findings go in the same direction as previous in vivo 
studies,52-54 which showed that increasing the microporosity fostered osteoinduction of CaPs, 
although the range of SSAs analyzed were significantly smaller than the ones studied in the 
present work.
The in vitro study with rMSCs showed some contradictory results. A higher cell proliferation 
(Figure 2A) and more mature cell morphology (Figure 2B ) was observed for the cells seeded on 
CO3-CDHA discs compared with both Fine-and Coarse-CDHA discs. The low proliferation on 
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Fine- and Coarse-CDHA agrees with previous results and was associated to the specific 
chemical and topographical features of these materials.55 It is important to mention that 
phalloidin stains F-actin, present in well-organized cytoskeleton, as observed in CO3-CDHA 
samples. The blurry staining observed in Fine- and Coarse-CDHA indicates a poorly organized 
cytoskeleton usually associated to immature focal adhesions and reduced cell proliferation.56 
However, the RT-qPCR analysis showed, as a general trend, higher expression of osteogenic 
genes for the cells cultured on Fine- and Coarse-CDHA than on CO3-CDHA samples, with no 
significant differences between the two undoped CDHA substrates (Supporting Information, 
Figure S2). This enhanced differentiation may also contribute to the reduction in cell 
proliferation.57 In general, gene expression increased between 6 h and 1 d of incubation, 
decreasing afterwards, as observed in previous studies.56 The increase in OCN gene 
expression at day 3 motivated the analysis of this gene at longer periods of incubation. 
Interestingly, these results were obtained without the addition of osteogenic medium, indicating 
that differentiation was induced by the topographical and chemical features of the CDHA 
surface, since no significant ionic fluctuations in the cell culture medium were observed 
(Supporting Information, Figure S4).”
These results, which can seem contradictory when compared with the ectopic bone formation, 
are a clear indication of the limitations of the static in vitro cell cultures to model the in vivo 
scenario, and reveal that the mechanism leading to osteoinduction cannot be reduced to a 
simple and direct interaction between material and MSCs. The mechanism is in fact far more 
complex and involves numerous intermediate processes and interactions, which are overlooked 
in a simple in vitro MSC cell culture study. Indeed, some studies have already proved the key 
role played by macrophages and osteoclasts in osteoinduction.26,27,53 The osteogenic growth 
factors secreted by these cells,58-61 together with the release of calcium and phosphate ions 
when resorbing the materials,62-65 are deemed to trigger the osteogenic differentiation of MSCs. 
In this line, we analyzed in a recent in vitro study the effect of different nanostructures of 
biomimetic CDHA on osteoimmunomodulation. We observed that macrophages were sensitive 
to the nanostructural features and, when cultured on needle-like Fine-CDHA substrates, the 
cytokines generated by macrophages were able to trigger osteoblastic differentiation and 
osteogenesis.15
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Regarding the degradation behavior, large differences were observed between the different 
foams, despite the identical or similar chemical composition between groups. Coarse-CDHA 
foams, with the lowest SSA, were the least resorbable scaffolds, being the only group where 
scaffold resorption did not progress overtime (Figure 6A). In contrast, Fine-CDHA and CO3-
CDHA scaffolds showed a superior and progressive resorption, with statistically significant 
differences at 12 weeks compared with Coarse-CDHA constructs (Figure 6A). Since body fluids 
are supersaturated regarding CDHA and CO3-CDHA, the degradation observed should be 
attributed to cell activity. In fact, a larger number of osteoclast-like cells were detected in both 
groups compared with that observed in Coarse-CDHA samples. 
Two different parameters can contribute to a higher cell-mediated degradation of a scaffold: i) 
the presence of a larger number of bone-resorbing cells, in this case osteoclast-like 
multinucleated cells; ii) the higher sensitivity of the material to the acidic pH produced by the 
bone-resorbing cells. Regarding the first factor, a higher number of osteoclast-like cells were 
observed both in the Fine- and CO3-CDHA foams compared with the Coarse-CDHA scaffolds in 
the histological analysis, which would contribute to the higher degradation rate observed in 
those groups. On top of this, the susceptibility of the biomaterial to acidic degradation is typically 
affected by the SSA and the chemical composition of the substrate. Thus, foams with higher 
SSA (i.e., Fine- and CO3-CDHA foams) are more reactive, and therefore more susceptible to 
acidic degradation. With regards to changes in the chemical composition, despite carbonate 
incorporation in the crystal lattice of stoichiometric HA is well known to disturb the crystal lattice 
enhancing reactivity,20,21,36 we were able to prove in an earlier work that carbonate incorporation 
in an already distorted calcium deficient HA did not have much influence on reactivity.13 Thus, 
we believe that the superior degradation of the carbonate containing foams implies a major 
recruitment of osteoclast-like cells on this particular substrate.
Previous in vitro22,23,25 and in vivo studies24,29,30,32,35 already reported the promotion of the 
osteoclastic activity by natural or synthetic carbonated apatites. The results found in the present 
work demonstrate that both carbonate content and SSA can be used to tune degradation. 
However, the fact that carbonate doping entailed also a change in crystal size and SSA 
Page 23 of 32
ACS Paragon Plus Environment






























































precluded the possibility to evaluate independently the effect of carbonate doping and textural 
properties. 
Interestingly, the higher activity of osteoclastic-like cells observed in the Fine- and CO3-CDHA 
foams was associated to a superior osteoinductive potential compared to the Coarse-CDHA 
constructs. This, indeed, contrasts to previous works, in which the high resorption rate showed 
by carbonated apatite scaffolds, instead of being beneficial for osteoinduction, definitely 
hindered it.33,34,36  Carbonated apatites with a SSA of 7-10 m2/g and 3-8 wt% of carbonate were 
claimed to lack the stable three-dimensional network needed to enable bone formation,33,34,36 
and it was postulated that there was a maximum SSA that beneficially affects osteoinduction.33 
In contrast, the nanostructured Fine- and CO3-CDHA analyzed in this work, with much higher 
SSA values (30-40 m2/g), as well as a higher carbonate content (12 wt%)  in the case of CO3-
CDHA, simultaneously presented high rates of resorption and large amounts of bone formation 
in an ectopic site.
4.2 Effect of nanostructure and carbonate doping on bone healing 
In order to assess the correlation between the osteoinductive potential and bone healing 
capacity, the same biomaterials were implanted orthotopically in the same dogs used for the 
intramuscular implantation study. Histological evaluation indicated that all scaffolds were well 
integrated in the cortical bone without any inflammatory adverse reaction. Similarly to what was 
observed intramuscularly, all groups showed a widespread angiogenesis within the macropores 
of the constructs (Supporting Information, Figure S3), which confirmed the appropriate pore 
interconnectivity, as well as the good biocompatibility of all three types of scaffolds, as 
previously reported in similar in vivo studies were CDHA66-68 and carbonated 
hydroxyapatite24,29,32,35,36 were evaluated orthotopically. 
The main finding was that the scaffolds with higher osteoinductivity, namely Fine-CDHA and 
CO3-CDHA, accelerated and promoted osteogenesis orthotopically (Figure 7), as demonstrated 
by the significantly higher percentage of newly formed bone after 6 and 12 weeks compared 
with the poorly osteoinductive Coarse-CDHA constructs (Figure 8A). Interestingly, whereas 
considerable bone ingrowth was indentified in the peripheral regions of all scaffolds, as a result 
of their excellent osteoconductive properties triggered by the open and interconnected 
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macropores, negligible amounts of bone were noted in the centre of the Coarse-CDHA scaffolds 
at 6 weeks (Figure 7A). In contrast, the early presence of new bone formation in the centre of 
the bone defects treated with the Fine- and CO3-CDHA scaffolds (Figure 7A) could be ascribed 
to the high intrinsic osteoinductive capacity of these materials, demonstrated in the ectopic 
implantation experiment. At 12 weeks, the results followed the same trend, as Fine- and CO3-
CDHA scaffolds exhibited a complete bone bridging and filling the full-thickness of cortical 
defects, whereas bone formation was significantly inferior in the Coarse-CDHA scaffolds (Figure 
7B and 8A). It is worth mentioning that a good correlation among osteoinduction and bone 
healing capacity has been described in previous studies for sintered ceramics.36,69,70
A good match was found also when comparing the resorption behaviour in orthotopic and 
ectopic sites (Figures 6A and 8B). Fine-CDHA scaffolds promoted a significantly higher cell-
mediated resorption than Coarse-CDHA scaffolds after 12 weeks of implantation, being even 
higher in the CO3-CDHA group (Figure 8B). The resorption of Coarse-CDHA constructs 
implanted intraosseously did not progress overtime (Figure 8B), as already observed 
intramuscularly. The high cell-mediated resorption exhibited by the Fine-CDHA and, especially, 
by the CO3-CDHA scaffolds, in conjunction with their high osteoconductive and osteoinductive 
properties enabled an excellent synchronization between biomaterial resorption and new bone 
formation. This resulted in a percentage of newly formed bone at 12 weeks over a hundred per 
cent in these two groups (Figure 8A), since the percentage was calculated over the initial 
macropore volume. The macropore volume after implantation was greater than the initial one, 
and it was almost fully occupied by new bone.
Overall, the present results highlight on one side the importance of the nanocrystal morphology 
and SSA and suggest that there is a threshold value in terms of SSA necessary to activate the 
cell-mediated resorption and the associated osteoinductive potential, which determine the 
osteogenic capacity of the materials in a bony environment. Regarding the effect of carbonate 
doping, although it is not possible to separate it from the textural properties since its inclusion in 
the apatite entails also a change in crystal morphology and an increase in SSA, it clearly 
increases degradation without impairing the osteoinductive properties.  
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The results obtained in the present study demonstrate that the idea of mimicking the mineral 
phase of bone is a powerful approach to design bone substitutes with enhanced performance. 
The size and morphology of the nanocrystals, as well as the presence of carbonate, allow 
tuning the osteoinductive and osteogenic potentials as well as the degradation profile of the 
CDHA. Moreover, those materials with textural and compositional properties closer to the 
biological apatite exhibited better synchronization between material resorption and bone 
formation. This suggests that biomimetic CDHA is able to enter the natural bone remodeling 
process, being transformed by the cells using the same mechanisms by which they remodel the 
extracellular matrix. Further studies are required in order to verify this hypothesis and clarify the 
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